SCHEMBL27685261

SCHEMBL27685261

C=CC(c1ccc(C)cc1)S(=O)(=O)n1cc(-c2ccccc2Cl)c(OCc2ccccc2)n1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.32
FFAR1 O14842 1/20 0.32
AR P10275 1/20 0.32
MAPK14 Q16539 1/20 0.32
NPC1 O15118 1/20 0.31
HTT P42858 1/20 0.31
CD4 P01730 2/20 0.31
MAPT P10636 3/20 0.31
LMNA P02545 2/20 0.31
CYP3A4 P08684 2/20 0.31
CYP2C19 P33261 2/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
PSEN1 P49768 1/20 0.31
PSEN2 P49810 1/20 0.31
APH1B Q8WW43 1/20 0.31
NCSTN Q92542 1/20 0.31
APH1A Q96BI3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27685275 0.89 FFAR1 (0.33) GRM5FFAR1ARCD4MAPT
SCHEMBL27666327 0.89 LMNA (0.36) GRM5ARNPC1CD4MAPT
SCHEMBL27666310 0.88 CNR1 (0.37) GRM5MAPTLMNACYP3A4CYP1A2
SCHEMBL28765488 0.86 FFAR1 (0.35) GRM5FFAR1CYP2C9PSEN1PSEN2
SCHEMBL27685439 0.86 KDM4E (0.32) ARNPC1MAPTLMNASMN1; SMN2
SCHEMBL27666643 0.84 LMNA (0.34) ARNPC1HTTCD4MAPT
SCHEMBL27685347 0.84 ALDH1A1 (0.36) GRM5NPC1HTTMAPTLMNA
SCHEMBL27666580 0.84 AR (0.34) ARNPC1HTTCD4MAPT
SCHEMBL28761518 0.82 LMNA (0.31) ARHTTMAPTLMNASMN1; SMN2
SCHEMBL28765462 0.81 PARP10 (0.39) MAPTLMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102174017-A Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions AVENTIS PHARMA SA 2011-09-07 CN claimed
CN-1906172-A Pyrazole derivatives as medicaments for the treatment of acute or chronic neuronal degeneration AVENTIS PHARMA SA (FR) 2007-01-31 CN claimed
CN-102174017-A Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions AVENTIS PHARMA SA 2011-09-07 CN disclosed
CN-1906172-A Pyrazole derivatives as medicaments for the treatment of acute or chronic neuronal degeneration AVENTIS PHARMA SA (FR) 2007-01-31 CN disclosed